Year |
Citation |
Score |
2014 |
Iltis I, Choi J, Vollmers M, Shenoi M, Bischof J, Metzger GJ. In vivo detection of the effects of preconditioning on LNCaP tumors by a TNF-α nanoparticle construct using MRI. Nmr in Biomedicine. 27: 1063-9. PMID 24980267 DOI: 10.1002/Nbm.3157 |
0.676 |
|
2013 |
Shenoi MM, Iltis I, Choi J, Koonce NA, Metzger GJ, Griffin RJ, Bischof JC. Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy. Molecular Pharmaceutics. 10: 1683-94. PMID 23544801 DOI: 10.1021/Mp300505W |
0.679 |
|
2013 |
Shenoi MM, Iltis I, Choi J, Koonce NA, Metzger GJ, Griffin RJ, Bischof JC. 10. Nanoparticle delivered vascular disrupting agents (VDAs): a new opportunity in multimodal cancer treatment Cryobiology. 66: 345. DOI: 10.1016/J.Cryobiol.2013.02.016 |
0.68 |
|
2012 |
Cressman EN, Geeslin MG, Shenoi MM, Hennings LJ, Zhang Y, Iaizzo PA, Bischof JC. Concentration and volume effects in thermochemical ablation in vivo: results in a porcine model. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 28: 113-21. PMID 22335225 DOI: 10.3109/02656736.2011.644621 |
0.492 |
|
2012 |
Cressman EN, Shenoi MM, Edelman TL, Geeslin MG, Hennings LJ, Zhang Y, Iaizzo PA, Bischof JC. In vivo comparison of simultaneous versus sequential injection technique for thermochemical ablation in a porcine model. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 28: 105-12. PMID 22335224 DOI: 10.3109/02656736.2011.644620 |
0.489 |
|
2011 |
Shenoi MM, Shah NB, Griffin RJ, Vercellotti GM, Bischof JC. Nanoparticle preconditioning for enhanced thermal therapies in cancer. Nanomedicine (London, England). 6: 545-63. PMID 21542691 DOI: 10.1016/J.Cryobiol.2011.09.036 |
0.658 |
|
2010 |
Pedro RN, Thekke-Adiyat T, Goel R, Shenoi M, Slaton J, Schmechel S, Bischof J, Anderson JK. Use of tumor necrosis factor-alpha-coated gold nanoparticles to enhance radiofrequency ablation in a translational model of renal tumors. Urology. 76: 494-8. PMID 20451965 DOI: 10.1016/J.Urology.2010.01.085 |
0.637 |
|
2010 |
Venkatasubramanian RT, Wolkers WF, Shenoi MM, Barocas VH, Lafontaine D, Soule CL, Iaizzo PA, Bischof JC. Freeze-thaw induced biomechanical changes in arteries: role of collagen matrix and smooth muscle cells. Annals of Biomedical Engineering. 38: 694-706. PMID 20108044 DOI: 10.1007/S10439-010-9921-9 |
0.623 |
|
2009 |
Shenoi MM, Anderson J, Bischof JC. Nanoparticle enhanced thermal therapies. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2009: 1979-82. PMID 19964027 DOI: 10.1109/IEMBS.2009.5333447 |
0.549 |
|
2009 |
Shenoi MM, Zhang X, Venkatasubramanian RT, Grassl ED, George L, Schmechel S, Coad JE, Bischof JC. CT visualization and histopathological assessment of cryoablation in pulmonary veins Proceedings of the Asme Summer Bioengineering Conference 2009, Sbc2009. 207-208. DOI: 10.1115/SBC2009-206640 |
0.62 |
|
2009 |
Shenoi M, Cressman E. Thermochemical Ablation: A Novel Technique for Solid Tumor Therapy Journal of Medical Devices. 3. DOI: 10.1115/1.3147268 |
0.415 |
|
2009 |
Pedro R, Thekke-Adiyat K, Shenoi M, Goel R, Schmechel S, Slaton J, Bischof J, Anderson K. Molecular Enhancement of Thermal Ablation Therapies Using TNF-α-Coated Gold Nanoparticles in a Translational Model of Renal Tumors Journal of Medical Devices. 3. DOI: 10.1115/1.3135192 |
0.651 |
|
2009 |
Shenoi M, Zhang X, Bischof J, George L. CT Visualization of Cryoablation in Pulmonary Veins Journal of Medical Devices. 3. DOI: 10.1115/1.3135157 |
0.559 |
|
2008 |
Zhang X, Leng C, Shenoi MM, Bischof JC. 57. Multi-probe cryosurgical treatments: An experimental and computational study confirms probe cooling power is probe number and placement dependent Cryobiology. 57: 326-327. DOI: 10.1016/J.Cryobiol.2008.10.058 |
0.45 |
|
Show low-probability matches. |